A Theranos investor from Texas asked so many probing questions about its technology and data that Elizabeth Holmes offered to buy out the man’s stake in the company for five times its value.
This week, Houston-based money manager Alan Eisenman testified in the ongoing Elizabeth Holmes fraud trial that he sought “straight answers” about the company’s work for several years. According to the Dallas Morning News, Eisenman, a financial planner, had a $1.2 million stake in the company. He is the latest witness to testify in the criminal trial that Holmes did not give straight answers about the company’s technology to investors or potential partners.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,